(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 17 September 2019 in relation to the Proposed Acquisition.)

Reference is made to the Company’s earlier announcements dated 17 September 2019, 11 February 2020 and 9 June 2020 made by the Board of Directors of FINTEC (“Board”) in relation to the Proposed Acquisition which are as follows: -

(i)      announcement dated 17 September 2019 (“First Announcement”) wherein Asiabio Capital Sdn. Bhd. (“Asiabio” or the “Purchaser”), a wholly-owned subsidiary of FINTEC, had entered into a Sale and Purchase of Shares Agreement (“First Agreement”) with Koh Hong Muan @ Koh Gak Siong (“KOH”) and Aimas Enterprise Sdn. Bhd. (“AIMAS”) (collectively referred to as the “Vendors”) for the acquisition by Asiabio of 32,800,000 ordinary shares in Komarkcorp Berhad (“KMC”) (“KMC Shares”) (“First Sale Shares”) from the Vendors at RM0.50 per KMC Share for a total cash consideration of RM16,400,000.00;

(ii)    announcement dated 11 February 2020 (“Second Announcement”) wherein Asiabio had entered into a supplemental agreement (“First Supplemental Agreement”) with the Vendors for the acquisition by Asiabio of an additional 8,080,000 KMC Shares (“Second Sale Shares”) from AIMAS at RM0.50 per KMC Share for a total cash consideration of RM4,040,000.00; and

(iii)     announcement dated 9 June 2020 (“Third Announcement”) wherein Asiabio had entered into another supplemental agreement (“Second Supplemental Agreement”) with the Vendors to vary the purchase price for the Proposed Acquisition as announced in the First and Second Announcements from RM0.50 per KMC Share to RM0.40 per KMC Share (“New Purchase Price”).

The Board of Directors of FINTEC wishes to further announce that the parties to the abovementioned Agreements have completed the Proposed Acquisition under the New Purchase Price by way of direct business transaction in accordance with the rules and directives of Bursa Securities, following the crediting of the KMC Shares to Asiabio on 2 July 2020.

This announcement is dated 3 July 2020.